Adrian Hargrave, CEO of SEEEN, explains how the Company is now funded through to profitability. Watch the video here.
Looks like vanv has been hacked for messing with paulo
Im going to bed now maybe some members can pick the bones out of it maybe translate the statement around 3 million. I think its down to interpretation.
Exceeding expectations
50 x3 would be 150 million.
???
AJ Bell
Doesnt it say that its exceeded by 50x expected
Dated 18-06-20
Must be a typo eh ?
Yeah i didnt post it for the figures i posted it to describe the crowded trade for all those that dont know why the sp is where it is.
If you know more about the figures then disregard that part it doesnt seem right to me either
Having delivered some of the best performances in the stock market so far in 2020, biotechnology shares have encountered a brutal correction over the last few weeks.
Investors might be feeling bruised after seeing in some cases shares losing over half of their values, while on average they have dropped just over 40% in value from recent highs, as the table shows.
Part of this downdraft is probably the result of too many investors chasing share prices higher on the latest regulatory announcements, creating what is sometimes called a crowded trade. This refers to buyers becoming more aggressive, paying little attention to the price they pay, almost willing to pay any price just to get a piece of the action.
Once the surge in buying is over, the market tends to fall back until it finds a better equilibrium between buyers and sellers. This can then be exacerbated by profit taking from buyers who got in early, looking to lock in their gains, leaving the latecomers licking their wounds.
Even so, all the companies in the table have at least doubled in value over the last six months, which is remarkable in current market conditions.
There was always going to be a time when investors focused more on the economic reality rather than just the story. This may mean that shares tread water while the fundamentals catch up with the valuation.
This looks like the case for leading performer Novacyt (NCYT:AIM) which launched one of the earliest Covid-19 test kits at the end of January. In a recent update the company confirmed it had received orders worth a total value of €135m with new contracts in Zimbabwe and South America.
Even after falling by half the market capitalisation of €144m is nearly 50 times expected 2020 net profits of €3m, according to data from Refinitiv.
Another reason for caution is the ever-increasing number of competing products that have appeared over the last few months, all hungry to meet the huge demand for coronavirus testing as well as antibody testing.
For example Omega Diagnostics (IDH:AIM) has interests in five Covid-19 testing opportunities, Genedrive (GDR:AIM) has developed a one-step, ready-to-go freeze dried test, while Avacta (AVCT:AIM) is due to launch a mass market testing strip in the summer.
In other words, the lions’ share of price gains for the sector are probably behind us and further gains will be driven by companies which can translate orders into profits.
You gotta laugh at trumps stunt with gilead obviously a stunt to get votes.
I hope compulsory licence doesnt come our way or can we make money from that ?
Gilead isnt up much lol
Elon Musk is going to send our test to each of his satelites
Fossil fuel up dominating the market in volume but this is down. Looks like junk to me
What caused that ?
The story is only just beginning !
AJ Bell refers to us as “market leaders”
Captain Stanley is a predator for sure.
he almost had me cutting losses in this because i saw gains elsewhere to equalise.
Care for a snail and some stinky cheese old boy ?
What !
Hello i was thinking the half in share price was to do with the virus and oil and thought that once things get into some normality that this share price would return to previous levels.
However with a second crossing in the pipeline
and Bozo claiming civil engineering will go ahead on infrastructure i am not so sure previous levels will return even with xmas factored in.
Id like nothing more than to buy in to this at this price to double my stake but i am thinking otherwise now
So nobody knows or is it a secret
Why has the stocks value halved ?
Sold a few other stocks to buy a lot more of this
How much did they pay for primer design just out of interest ?